Effect of curcuminoids on oxidative stress: A systematic review and meta-analysis of randomized controlled trials

Journal of Functional Foods

Volumn 18, Issue , 2015, Pages 898-909

  Sahebkar, Amirhossein ^a,b   Serban, Maria Corina ^c   Ursoniu, Sorin ^c   Banach, Maciej ^d  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^d MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Curcuma longa; Curcumin supplementation; Curcuminoids; Oxidative stress; SOD; Superoxide dismutase

Indexed keywords

EID: 84928379905     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2015.01.005     Document Type: Review

References (85)

1. Aditya N.P., Shim M., Yang H., Lee Y.J., Ko S. Antiangiogenic effect of combined treatment with curcumin and genistein on human prostate cancer cell line. Journal of Functional Foods 2014, 8:204-213.
2. Aggarwal B.B., Sung B. Pharmacological basis for the role of curcumin in chronic diseases: An age-old spice with modern targets. Trends in Pharmacological Sciences 2009, 30:85-94.
3. Amer M.A., Ghattas M.H., Abo-Elmatty D.M., Abou-El-Ela S.H. Evaluation of glutathione S-transferase P1 genetic variants affecting type-2 diabetes susceptibility and glycemic control. Archives of Medical Science 2012, 8:631-636.
4. Ammon H.P., Anazodo M.I., Safayhi H., Dhawan B.N., Srimal R.C. Curcumin: A potent inhibitor of leukotriene B4 formation in rat peritoneal polymorphonuclear neutrophils (PMNL). Planta Medica 1992, 58:226.
5. Anand P., Thomas S.G., Kunnumakkara A.B., Sundaram C., Harikumar K.B., Sung B., Tharakan S.T., Misra K., Priyadarsini I.K., Rajasekharan K.N., Aggarwal B.B. Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochemical Pharmacology 2008, 76:1590-1611.
6. Atal C.K., Dubey R.K., Singh J. Biochemical basis of enhanced drug bioavailability by piperine: Evidence that piperine is a potent inhibitor of drug metabolism. The Journal of Pharmacology and Experimental Therapeutics 1985, 232:258-262.
7. Augustyniak A., Bartosz G., Cipak A., Duburs G., Horakova L., Luczaj W., Majekova M., Odysseos A.D., Rackova L., Skrzydlewska E., Stefek M., Strosova M., Tirzitis G., Venskutonis P.R., Viskupicova J., Vraka P.S., Zarkovic N. Natural and synthetic antioxidants: An updated overview. Free Radical Research 2010, 44:1216-1262.
8. Bajad S., Bedi K.L., Singla A.K., Johri R.K. Piperine inhibits gastric emptying and gastrointestinal transit in rats and mice. Planta Medica 2001, 67:176-179.
9. Banach M., Serban C., Aronow W.S., Rysz J., Dragan S., Lerma E.V., Apetrii M., Covic A. Lipid, blood pressure and kidney update 2013. International Urology and Nephrology 2014, 46:947-961.
10. Bartnicki P., Fijałkowski P., Majczyk M., Błaszczyk J., Banach M., Rysz J. Effect of methoxy polyethylene glycol-epoetin beta on oxidative stress in predialysis patients with chronic kidney disease. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 2013, 19:954.
11. Basnet P., Skalko-Basnet N. Curcumin: An anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules 2011, 16:4567-4598.
12. Borenstein M., Hedges L., Higgins J., Rothstein H. Comprehensive meta-analysis version 2 2005, 104. Biostat, Englewood, NJ.
13. Carillon J., Rouanet J.M., Cristol J.P., Brion R. Superoxide dismutase administration, a potential therapy against oxidative stress related diseases: Several routes of supplementation and proposal of an original mechanism of action. Pharmaceutical Research 2013, 30:2718-2728.
14. Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: A component of tumeric (Curcuma longa). Journal of Alternative and Complementary Medicine (New York, N.Y.) 2003, 9:161-168.
15. Chaudiere J., Ferrari-Iliou R. Intracellular antioxidants: From chemical to biochemical mechanisms. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 1999, 37:949-962.
16. Cuomo J., Appendino G., Dern A.S., Schneider E., McKinnon T.P., Brown M.J., Togni S., Dixon B.M. Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. Journal of Natural Products 2011, 74:664-669.
17. Darvesh A.S., Carroll R.T., Bishayee A., Novotny N.A., Geldenhuys W.J., Van der Schyf C.J. Curcumin and neurodegenerative diseases: A perspective. Expert Opinion on Investigational Drugs 2012, 21:1123-1140.
18. Davies K.J. Oxidative stress: The paradox of aerobic life. Biochemical Society Symposium 1995, 61:1-31.
19. Di Majo D., La Guardia M., Leto G., Crescimanno M., Flandina C., Giammanco M. Flavonols and flavan-3-ols as modulators of xanthine oxidase and manganese superoxide dismutase activity. International Journal of Food Sciences and Nutrition 2014, 65:886-892.
20. DiSilvestro R.A., Joseph E., Zhao S., Bomser J. Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people. Nutrition Journal 2012, 11:79.
21. Duval S., Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000, 56:455-463.
22. Fridovich I. Superoxide radical and superoxide dismutases. Annual Review of Biochemistry 1995, 64:97-112.
23. Giri S.N., Misra H.P. Fate of superoxide dismutase in mice following oral route of administration. Medical Biology 1984, 62:285-289.
24. Gupta S.C., Patchva S., Koh W., Aggarwal B.B. Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clinical and Experimental Pharmacology and Physiology 2012, 39:283-299.
25. Gürtler R. Risk assessment of food additives. Regulatory toxicology 2014, 803-812. Springer, Berlin Heidelberg. F.-X. Reichl, M. Schwenk (Eds.).
26. Hamam F., Al-Remawi M. Novel delivery system of curcumin through transdermal route using sub-micronized particles composed of mesoporous silica and oleic acid. Journal of Functional Foods 2014, 8:87-99.
27. Han Y., Chin Tan T.M., Lim L.Y. In vitro and in vivo evaluation of the effects of piperine on P-gp function and expression. Toxicology and Applied Pharmacology 2008, 230:283-289.
28. Hashimoto N., Noda T., Kim S.J., Yamauchi H., Takigawa S., Matsuura-Endo C., Suzuki T., Han K.H., Fukushima M. Colored potato extracts induce superoxide dismutase-2 mRNA via ERK1/2 pathway in HepG2 cells. Plant Foods for Human Nutrition (Dordrecht, Netherlands) 2010, 65:266-270.
29. Hirofumi N., Jinsyo T., Seiichi K. Anti-inflammatory and anti-oxidative effect of curcumin in connective tissue type mast cell. Journal of Functional Foods 2013, 5:763-772.
30. Hong J., Bose M., Ju J., Ryu J.H., Chen X., Sang S., Lee M.J., Yang C.S. Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: Effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase. Carcinogenesis 2004, 25:1671-1679.
31. Huber W., Menander-Huber K.B., Saifer M.G., Williams L.D. Bioavailability of superoxide dismutase: Implications for the anti-inflammatory action mechanism of orgotein. Agents and Actions. Supplements 1980, 7:185-195.
32. Jadad A.R., Moore R.A., Carroll D., Jenkinson C., Reynolds D.J., Gavaghan D.J., McQuay H.J. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?. Controlled Clinical Trials 1996, 17:1-12.
33. Jain S.K., Rains J., Croad J., Larson B., Jones K. Curcumin supplementation lowers TNF-alpha, IL-6, IL-8, and MCP-1 secretion in high glucose-treated cultured monocytes and blood levels of TNF-alpha, IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats. Antioxidants and Redox Signaling 2009, 11:241-249.
34. Johnston B.D., DeMaster E.G. Suppression of nitric oxide oxidation to nitrite by curcumin is due to the sequestration of the reaction intermediate nitrogen dioxide, not nitric oxide. Nitric Oxide: Biology and Chemistry 2003, 8:231-234.
35. Kang B.Y., Chung S.W., Chung W., Im S., Hwang S.Y., Kim T.S. Inhibition of interleukin-12 production in lipopolysaccharide-activated macrophages by curcumin. European Journal of Pharmacology 1999, 384:191-195.
36. Kedziora-Kornatowska K., Czuczejko J., Motyl J., Szewczyk-Golec K., Kozakiewicz M., Pawluk H., Kedziora J., Blaszczak R., Banach M., Rysz J. Effects of coenzyme Q10 supplementation on activities of selected antioxidative enzymes and lipid peroxidation in hypertensive patients treated with indapamide. A pilot study. Archives of Medical Science 2010, 6:513-518.
37. Kim K.H., Lee E.N., Park J.K., Lee J.R., Kim J.H., Choi H.J., Kim B.S., Lee H.W., Lee K.S., Yoon S. Curcumin attenuates TNF-alpha-induced expression of intercellular adhesion molecule-1, vascular cell adhesion molecule-1 and proinflammatory cytokines in human endometriotic stromal cells. Phytotherapy Research 2012, 26:1037-1047.
38. Kowalski J., Banach M., Barylski M., Irzmanski R., Pawlicki L. Carvedilol modifies antioxidant status of patients with stable angina. Cellular and Molecular Biology Letters 2008, 13:230-239.
39. Lin J.K. Molecular targets of curcumin. Advances in Experimental Medicine and Biology 2007, 595:227-243.
40. Lin J.K., Pan M.H., Lin-Shiau S.Y. Recent studies on the biofunctions and biotransformations of curcumin. Biofactors (Oxford, England) 2000, 13:153-158.
41. Marchiani A., Rozzo C., Fadda A., Delogu G., Ruzza P. Curcumin and curcumin-like molecules: From spice to drugs. Current Medicinal Chemistry 2014, 21:204-222.
42. Marczylo T.H., Verschoyle R.D., Cooke D.N., Morazzoni P., Steward W.P., Gescher A.J. Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine. Cancer Chemotherapy and Pharmacology 2007, 60:171-177.
43. Menon V.P., Sudheer A.R. Antioxidant and anti-inflammatory properties of curcumin. The molecular targets and therapeutic uses of curcumin in health and disease 2007, 105-125. Springer, Berlin Heidelberg. B.B. Aggarwal, Y.-J. Surh, S. Shishodia (Eds.).
44. Michalska M., Gluba A., Mikhailidis D.P., Nowak P., Bielecka-Dabrowa A., Rysz J., Banach M. The role of polyphenols in cardiovascular disease. Medical Science Monitor 2010, 16:RA110-RA119.
45. Mohajer A., Ghayour-Mobarhan M., Parizadeh S.M.R., Tavallaie S., Rajabian M., Sahebka A. Effects of supplementation with curcuminoids on serum copper and zinc concentrations and superoxide dismutase enzyme activity in obese subjects. Trace Elements and Electrolytes 2014, 32:16-21.
46. Mohammadi A., Sahebkar A., Iranshahi M., Amini M., Khojasteh R., Ghayour-Mobarhan M., Ferns G.A. Effects of supplementation with curcuminoids on dyslipidemia in obese patients: A randomized crossover trial. Phytotherapy Research 2013, 27:374-379.
47. Moher D., Cook D.J., Jadad A.R., Tugwell P., Moher M., Jones A., Pham B., Klassen T.P. Assessing the quality of reports of randomised trials: Implications for the conduct of meta-analyses. Assessing the Quality of Reports of Randomised Trials: Implications for the Conduct of Meta-Analyses 1999, 3:1-98.
48. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Annals of Internal Medicine 2009, 151:264-269.
49. Moon D.O., Kim M.O., Lee H.J., Choi Y.H., Park Y.M., Heo M.S., Kim G.Y. Curcumin attenuates ovalbumin-induced airway inflammation by regulating nitric oxide. Biochemical and Biophysical Research Communications 2008, 375:275-279.
50. Nelson S.K., Bose S.K., Grunwald G.K., Myhill P., McCord J.M. The induction of human superoxide dismutase and catalase in vivo: A fundamentally new approach to antioxidant therapy. Free Radical Biology and Medicine 2006, 40:341-347.
51. Nguyen T.A., Friedman A.J. Curcumin: A novel treatment for skin-related disorders. Journal of Drugs in Dermatology 2013, 12:1131-1137.
52. Panahi Y., Badeli R., Karami G.R., Sahebkar A. Investigation of the efficacy of adjunctive therapy with bioavailability-boosted curcuminoids in major depressive disorder. Phytotherapy Research 2014, 29:17-21.
53. Panahi Y., Beiraghdar S.A., Hosseini F., Nouzari S.M., Jalalian H.R., Sahebkar A. Antioxidant effects of bioavailability-enhanced curcuminoids in patients with solid tumors: A randomized double-blind placebo-controlled trial. Journal of Functional Foods 2014, 6:615-622.
54. Panahi Y., Ghanei M., Bashiri S., Hajihashemi A., Sahebkar A. Short-term curcuminoids supplementation for chronicpulmonary complications due to sulfur mustard intoxication: Positive results of a randomized double-blind placebo-controlled trial. Drug Research 2014.
55. Panahi Y., Ghanei M., Hajhashemi A., Sahebkar A. Effects of curcuminoids-piperine combination on systemic oxidative stress, clinical symptoms and quality of life in subjects with chronic pulmonary complications due to sulfur mustard: A randomized controlled trial. Journal of Dietary Supplements 2014, 10.3109/19390211.2014.952865.
56. Panahi Y., Khalili N., Hosseini M.S., Abbasinazari M., Sahebkar A. Lipid-modifying effects of adjunctive therapy with curcuminoids-piperine combination in patients with metabolic syndrome: Results of a randomized controlled trial. Complementary Therapies in Medicine 2014, 22:851-857.
57. Panahi Y., Rahimnia A.R., Sharafi M., Alishiri G., Saburi A., Sahebkar A. Curcuminoid treatment for knee osteoarthritis: A randomized double-blind placebo-controlled trial. Phytotherapy Research 2014, 28:1625-1631.
58. Panahi Y., Saadat A., Beiraghdar F., Sahebkar A. Adjuvant therapy with bioavailability-boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors: A randomized double-blind placebo-controlled trial. Phytotherapy Research 2014, 28:1461-1467.
59. Panahi Y., Sahebkar A., Amiri M., Davoudi S.M., Beiraghdar F., Hoseininejad S.L., Kolivand M. Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: Results of a randomised, double-blind, placebo-controlled trial. The British Journal of Nutrition 2012, 108:1272-1279.
60. Panahi Y., Sahebkar A., Parvin S., Saadat A. A randomized controlled trial on the anti-inflammatory effects of curcumin in patients with chronic sulphur mustard-induced cutaneous complications. Annals of Clinical Biochemistry 2012, 49:580-588.
61. Park K., Kwon I.C., Park K. Oral protein delivery: Current status and future prospect. Reactive and Functional Polymers 2011, 71:280-287.
62. Prasad S., Gupta S.C., Tyagi A.K., Aggarwal B.B. Curcumin, a component of golden spice: From bedside to bench and back. Biotechnology Advances 2014, 32:1053-1064.
63. Rahimnia A., Panahi Y., Sharafi M., Alishiri G., Sahebkar A. Mitigation of systemic oxidative stress by curcuminoids in osteoarthritis: Results of a randomized controlled trial. Journal of Dietary Supplements 2014.
64. Ray S., Chattopadhyay N., Mitra A., Siddiqi M., Chatterjee A. Curcumin exhibits antimetastatic properties by modulating integrin receptors, collagenase activity, and expression of Nm23 and E-cadherin. Journal of Environmental Pathology, Toxicology and Oncology 2003, 22:49-58.
65. Reen R.K., Jamwal D.S., Taneja S.C., Koul J.L., Dubey R.K., Wiebel F.J., Singh J. Impairment of UDP-glucose dehydrogenase and glucuronidation activities in liver and small intestine of rat and guinea pig in vitro by piperine. Biochemical Pharmacology 1993, 46:229-238.
66. Rosenfeld W.N., Davis J.M., Parton L., Richter S.E., Price A., Flaster E., Kassem N. Safety and pharmacokinetics of recombinant human superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome. Pediatrics 1996, 97:811-817.
67. Sahebkar A. Does PPARgamma2 gene Pro12Ala polymorphism affect nonalcoholic fatty liver disease risk? Evidence from a meta-analysis. DNA and Cell Biology 2013, 32:188-198.
68. Sahebkar A. Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome?. Biofactors (Oxford, England) 2013, 39:197-208.
69. Sahebkar A. Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis. Phytotherapy Research 2014, 28:633-642.
70. Sahebkar A. Curcuminoids for the management of hypertriglyceridaemia. Nature Reviews Cardiology 2014, 11:123.
71. Sahebkar A. Low-density lipoprotein is a potential target for curcumin: Novel mechanistic insights. Basic & Clinical Pharmacology & Toxicology 2014, 114:437-438.
72. Sahebkar A., Mohammadi A., Atabati A., Rahiman S., Tavallaie S., Iranshahi M., Akhlaghi S., Ferns G.A., Ghayour-Mobarhan M. Curcuminoids modulate pro-oxidant-antioxidant balance but not the immune response to heat shock protein 27 and oxidized LDL in obese individuals. Phytotherapy Research 2013, 27:1883-1888.
73. Shah B.H., Nawaz Z., Pertani S.A., Roomi A., Mahmood H., Saeed S.A., Gilani A.H. Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor- and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and Ca2+ signaling. Biochemical Pharmacology 1999, 58:1167-1172.
74. Shehzad A., Khan S., Sup Lee Y. Curcumin molecular targets in obesity and obesity-related cancers. Future Oncology (London, England) 2012, 8:179-190.
75. Shen L.R., Xiao F., Yuan P., Chen Y., Gao Q.K., Parnell L.D., Meydani M., Ordovas J.M., Li D., Lai C.Q. Curcumin-supplemented diets increase superoxide dismutase activity and mean lifespan in Drosophila. Age (Dordrecht, Netherlands) 2013, 35:1133-1142.
76. Shoba G., Joy D., Joseph T., Majeed M., Rajendran R., Srinivas P.S. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Medica 1998, 64:353-356.
77. Skarpanska-Stejnborn A., Pilaczynska-Szczesniak L., Basta P., Deskur-Smielecka E., Woitas-Slubowska D., Adach Z. Effects of oral supplementation with plant superoxide dismutase extract on selected redox parameters and an inflammatory marker in a 2000-m rowing-ergometer test. International Journal of Sport Nutrition and Exercise Metabolism 2011, 21:124.
78. Swart P.J., Hirano T., Kuipers M.E., Ito Y., Smit C., Hashida M., Nishikawa M., Beljaars L., Meijer D.K., Poelstra K. Targeting of superoxide dismutase to the liver results in anti-inflammatory effects in rats with fibrotic livers. Journal of Hepatology 1999, 31:1034-1043.
79. Tu C.T., Yao Q.Y., Xu B.L., Zhang S.C. Curcumin protects against concanavalin A-induced hepatitis in mice through inhibiting the cytoplasmic translocation and expression of high mobility group box 1. Inflammation 2013, 36:206-215.
80. Uto-Kondo H., Ayaori M., Kishimoto Y., Adachi T., Takiguchi S., Yakushiji E., Sasaki M., Komatsu T., Kondo K., Ikewaki K. Consumption of polyphenol-rich juar tea increases endothelium-bound extracellular superoxide dismutase levels in men with metabolic syndrome: Link with LDL oxidizability. International Journal of Food Sciences and Nutrition 2013, 64:407-414.
81. Wojcik M., Burzynska-Pedziwiatr I., Wozniak L.A. A review of natural and synthetic antioxidants important for health and longevity. Current Medicinal Chemistry 2010, 17:3262-3288.
82. Yilmaz N. Relationship between paraoxonase and homocysteine: Crossroads of oxidative diseases. Archives of Medical Science 2012, 8:138-153.
83. Zhou H., Beevers C.S., Huang S. The targets of curcumin. Current Drug Targets 2011, 12:332-347.
84. Zidenberg-Cherr S., Keen C.L., Lonnerdal B., Hurley L.S. Dietary superoxide dismutase does not affect tissue levels. The American Journal of Clinical Nutrition 1983, 37:5-7.
85. Zlotogorski A., Dayan A., Dayan D., Chaushu G., Salo T., Vered M. Nutraceuticals as new treatment approaches for oral cancer - I: Curcumin. Oral Oncology 2013, 49:187-191.